Hikma races to launch generic versions of blockbuster obesity drugs
Pharma group looks to take advantage as Wegovy and Ozempic start to go off patent next year
Hikma
since
auto-detected in 4 stories
56 days ago
page 1 of 1
since
auto-detected in 4 stories
56 days ago
page 1 of 1